C9orf72 and amyotrophic lateral sclerosis: Antisense oligonucleotides targeted at C9orf72 mutant transcripts have shown promising results in ALS models and are currently in development for patients with C9orf72-related ALS (Riboldi et al., 2014; Martier et al., 2019).